Active Ingredient: TELBIVUDINE
Proprietary Name: TYZEKA
Dosage Form; Route of Administration: SOLUTION; ORAL
Strength: 100MG/5ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N022154
Product Number: 001
Approval Date: Apr 28, 2009
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Discontinued
Patent and Exclusivity Information